mt-3724

Recombinant proteinexperimental

Clinical trial activity

5 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Feb 1, 2015 (NCT02361346)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • mt-3724

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03645395Phase 2Dec 3, 2018Molecular Templates
NCT03488251Phase 2Aug 20, 2018Molecular Templates
NCT02715843N/ADec 1, 2015Molecular Templates
NCT02556346Phase 1Nov 1, 2015Molecular Templates
NCT02361346Phase 1Feb 1, 2015Molecular Templates
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Molecular TemplatesFor profit5532015
1 organizations
Page 1 / 1